Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Monthly adjustments help maintain financial health by adapting to income shifts, goals, and unexpected expenses with proactive planning.
24,646 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
A high-profile insider move shines a light on AI-driven demand for Willdan's engineering services. This piece breaks ...
A surprise leadership change jolted Copart’s stock, sparking an intraday drop. This article breaks down the why, what...
A major U.S. move targets a broker accused of trading stolen cyber tools, signaling a new turn in sanctions enforceme...
A new study finds AI chatbots misinterpret uncertainty terms, a misalignment that could influence personal-finance de...
Oracle isn't done spending on AI, and the move is shaking up how investors view cloud growth and profitability. This ...
A National Bureau of Economic Research paper shows escaping your income bracket no longer guarantees wealth, a findin...
When a 90-something woman faced a bank impostor at her doorstep, an observant Uber driver intervened. This article br...
Institutional moves can reveal much about a company’s future. This article breaks down why long path partners buys Al...
A famous moment at a royal event shows how public perception can ripple into your wallet. This guide translates that ...
Discover two AI stocks that Wall Street analysts believe could move significantly higher. Learn what makes them stron...
EPAM Systems sank this week after reporting earnings that beat the street but offered cautious 2026 guidance. This ar...